Anavex Life Sciences Corp (AVXL)

[Hosai]

Well looking into it he was at CRTX for only 6 months before resigning. I doubt he was in interviews saying he was very excited about their failed drug when discussing potential upcoming new treatments as he just did for Blarcamesine?

I can also see some differences in his paragraph upon joining each company:

CRTX - "“Based upon more than thirty years of clinical experience, I believe that gingipain inhibition potentially offers a clinically significant therapy for a variety of degenerative conditions,” said Dr. Sabbagh. “I look forward to sharing my clinical expertise with the Cortexyme team to further support the advancement of their pipeline for the treatment of degenerative diseases.”

AVXL - "I’m excited to join Anavex’s Scientific Advisory Board at this time of important progress of the Company. There is such a significant unmet medical need around the globe caused by Alzheimer’s disease and given the robust clinical data of blarcamesine (ANAVEX®2-73) in Alzheimer’s disease I look forward to joining the scientific team at Anavex to move forward a path for patients and their loved ones to be able to provide an effective therapeutic which can be taken orally and is generally safe.”